Warapen Treekit

@Aiims1742 @MDAndersonNews Thank you, Dr. Maitra for your longstanding support!

Congratulations to Subrata Sen & team @MDAndersonNews for their @NatureCellBio paper: RASH3D19 mediates RAS activation through a positive feedback loop in KRAS-mutant cancer nature.com/articles/s4155…

Proud to share our @NaturePortfolio research article: "RASH3D19 as a mediator of RAS pathway activation through a positive feedback loop in KRAS-mutant cancer", now out in Nature Cell Biology. Read it here: nature.com/articles/s4155… mdanderson.org/newsroom/resea…

In this @BrJCancer study, scientists from @MDAndersonNews discover that epigenetic activation of 🧦 SOX11 drives 🚙 recurrence of ductal carcinoma in-situ (DCIS) and progression 📈 to invasive cancer. 😎 Check it out: go.nature.com/3VbMKew

Examining the role of eEF1A2 in cancer, researchers at @MDAndersonNews find the factor normally interacts with the tumor suppressor #PTEN to repress the #CellCycle and degrade Aurora-A, but that the latter is more abundant in #BreastCancer tissues. scim.ag/67G

The most important paper of 2024 🤯

A riddle for scientists: what is (1) better than publishing in Nature, (2) more evil than reviewer 2, (3) the postdocs have it, (4) the Nobel prize winners need it, and (5) if you publish it you perish?

do athletes live longer than sedentary folks?

Calling all coffee enthusiasts! Exciting research reveals how caffeine influences #intestinal tumor initiation. Interested in learning more? Click the link ➡️ ow.ly/RisN50PQgYH

@pedrofsrocha @hospitaldelmar @IMIM_research @AstraZenecaES 👍🏻👍🏻👍🏻

Delighted to present initial translational results from the CANTÁBRICO study (phase IIIb trial of durvalumab plus platinum-etoposide as 1st line for patients with ES-SCLC) at #ELCC2023 #SCLC ⁦@hospitaldelmar⁩ ⁦@IMIM_research⁩ ⁦⁦@AstraZenecaES⁩

The one thing that only you control is your effort

Fascinating talk from @HansClevers on identifying pks E. Coli mutational signatures in intestinal organoid cultures. Elegant work and beautiful animations alongside. #AACR22

Cytotoxic CD4+ T cells in cancer: Expanding the immune effector toolbox dlvr.it/SFgDwD

@pedrofsrocha Hi Pedro, How is your life at home? Hiro & I are missing you :)

Great work Nick and team. Well done 👏🏻👏🏻

Augmented lipocalin-2 is a molecular feature of COPD-associated LUAD and counteracts LUAD development by maintaining anti-tumor immunity. atsjournals.org/doi/abs/10.116… #lungcancer #COPD #EndCancer @humam_kadara @AnsamSinjab

@deehk มันเก่าแล้วอ่ะ เห็นว่าจะปรับปรุงใหม่หลายทีแระ คงจะได้ฤกษ์ดีก็คราวนี้